In the ****** interview Cheryl stated the following
And I quote
"And through that engagement what we would get is that equity in whatever the asset is. And the most successful scenario would be that Petalion does develop quite a novel therapy using our dendrimer technology, and there is a successful exit and that's when we have our 22.5% equity gain"
